
|Videos|January 7, 2016
Dr. Arlene Sharpe on the Role of the PD-1 Pathway
Author(s)Arlene Sharpe, MD, PhD
Arlene Sharpe, MD, PhD, immunology faculty member, Harvard Medical School, discusses the biology of the PD-1 pathway.
Advertisement
Arlene Sharpe, MD, PhD, immunology faculty member, Harvard Medical School, discusses the biology of the PD-1 pathway.
The PD-1 pathway, which Sharpe’s lab helped define 15 years ago, inhibits immune responses, and protects against the development of autoimmunity. This prevents the activation and function of potentially pathogenic self reactive cells. The pathway also controls the resolution of inflammation, says Sharpe.
However, the most intriguing role of the PD-1 pathway is its ability to inhibit immune responses and allow tumors to avoid eradication, says Sharpe.
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
The OncFive: Top Oncology Articles for the Week of 5/31
3
From Toilet Cleaner to Thoracic Oncologist and Patient: How Ross Camidge Built a Life Worth Loving
4
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
5




































































